Sagent Pharm Inc (SGNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2010 | 12-2009 | |
| Sales | 74,056 | 29,222 |
| Cost of Goods | 65,013 | 28,785 |
| Gross Profit | 9,043 | 437 |
| Operating Expenses | 31,643 | 31,357 |
| Operating Income | -22,587 | -30,135 |
| Interest Expense | 1,129 | 467 |
| Other Income | -779 | 66 |
| Pre-tax Income | -24,495 | -30,536 |
| Net Income Continuous | -24,495 | -30,536 |
| Net Income | $-24,495 | $-30,536 |
| EPS Basic Total Ops | -12.53 | -17.16 |
| EPS Basic Continuous Ops | -12.53 | -17.13 |
| EPS Diluted Total Ops | -12.53 | -17.16 |
| EPS Diluted Continuous Ops | -12.53 | -17.13 |
| EPS Diluted Before Non-Recurring Items | -12.53 | N/A |
| EBITDA(a) | $-21,357 | $-25,909 |